IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo

Oncogene

Volumn 23, Issue 5, 2004, Pages 1125-1135

  Kim, Peter K M ^a   Armstrong, Michaele ^a   Liu, Ye ^a   Yan, Peng ^a   Bucher, Brian ^a   Zuckerbraun, Brian S ^a   Gambotto, Andrea ^a   Billiar, Timothy R ^a   Yim, John H ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Breast cancer; Caspase; Interferon regulatory factor 1 (IRF 1)

Indexed keywords

ADENOVIRUS VECTOR; CASPASE; CASPASE 3; CASPASE 7; CASPASE 8; INTERFERON REGULATORY FACTOR 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PROTEIN BAK;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE CONSTRUCT; GENE OVEREXPRESSION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; TUMOR GROWTH; UPREGULATION;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CASPASES; CELL LINE; CELL LINE, TUMOR; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; INJECTIONS, SUBCUTANEOUS; INTERFERON REGULATORY FACTOR-1; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; PHOSPHOPROTEINS; POLY(ADP-RIBOSE) POLYMERASES; PROTEINS; TRANSPLANTATION, ISOGENEIC;

ADENOVIRIDAE; ANIMALIA;

EID: 1442278664     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207023     Document Type: Article

References (53)

1. Baselga J and Norton L. (2002). Cancer Cell., 1, 319-322.
2. Bouker KB, Skaar TC, Fernandez D and Clarke R. (2002). Clin. Cancer Res., 5 (Suppl.) p53, Error of hope conference, Department of Defense, Breast Cancer Research Program.
3. Brodt P, Parhar R, Sankar P and Lala PK. (1985). Int. J. Cancer, 35, 265-273.
4. Chapman RS, Duff EK, Lourenco PC, Tonner E, Flint DJ, Clarke AR and Watson CJ. (2000). Oncogene, 19, 6386-6391.
5. Chang CH, Hammer J, Loh JE, Fodor WL and Flavell RA. (1992). Immunogenetics, 35, 378-384.
6. Doherty GM, Boucher L, Sorenson K and Lowney J. (2001). Ann. Surg., 233, 623-629.
7. Fujita T, Kimura Y, Miyamoto M, Barsoumian EL and Taniguchi T. (1989). Nature, 337, 270-272.
8. Geller DA, Nguyen D, Shapiro RA, Nussler A, Di Silvio M, Freeswick P, Wang SC, Tweardy DJ, Simmons RL and Billiar TR. (1993). Surgery, 114, 235-242.
9. Green DR and Evan GI. (2002). Cancer Cell., 1, 19-30.
10. Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T and Taniguchi T. (1989). Cell, 58, 729-739.
11. Harada H, Willison K, Sakakibara J, Miyamoto M, Fujita T and Taniguchi T. (1990). Cell, 63, 303-312.
12. Hardy S, Kitamura M, Harris-Stansil T, Dai Y and Phipps ML. (1997). J. Virol., 71, 1842-1849.
13. Ihle JN. (1996). Cell, 84, 331-334.
14. Jemal A, Thomas A, Murray T and Thun M. (2002). CA Cancer J. Clin., 52, 23-47.
15. Kano A, Haruyama T, Akaike T and Watanabe Y. (1999a). Biochem. Biophys. Res. Commun., 257, 672-677.
16. Kano A, Haruyama T, Akaike T and Watanabe Y. (1999b). Biochem. Biophys. Res. Commun., 257, 672-677.
17. Kashiwaba M, Tamura G and Ishida M. (1994). J. Cancer Res. Clin. Oncol., 120, 727-731.
18. Kim PK, Zamora R, Petrosko P and Billiar TR. (2001). Int. Immunopharmacol., 1, 1421-1441.
19. Kirchhoff S and Hauser H. (1999). Oncogene, 18, 3725-3736.
20. Kirchhoff S, Schaper F and Hauser H. (1993). Nucleic Acids Res., 21, 2881-2889.
21. Kirkwood JM, Ibrahim JG, Sosman JA, Sondak VK, Agarwala SS, Ernstoff MS and Rao U. (2001). J. Clin. Oncol., 19, 2370-2380.
22. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST and van Oers MH. (1994). Blood, 84, 1415-1420.
23. Kroger A, Dallugge A, Kirchhoff S and Hauser H. (2003). Oncogene, 22, 1045-1056.
24. Kroger A, Koster M, Schroeder K, Hauser H and Mueller PP. (2002). J. Interferon Cytokine Res., 22, 5-14.
25. Kroger A, Ortmann D, Krohne TU, Mohr L, Blum HE, Hauser H and Geissler M. (2001). Cancer Res., 61, 2609-2617.
26. Lee SH, Kim JW, Lee HW, Cho YS, Oh SH, Kim YJ, Jung CH, Zhang W and Lee JH. (2003). Oncogene, 22, 381-391.
27. Li Y, Maher P and Schubert D. (1997). J. Cell. Biol., 139, 1317-1324.
28. Nanni P, de Giovanni C, Lollini PL, Nicoletti G and Prodi G. (1983). Clin. Exp. Metastasis., 1, 373-380.
29. No D, Yao TP and Evans RM. (1996). Proc. Natl. Acad. Sci. USA, 93, 3346-3351.
30. Nguyen H, Lin R and Hiscott J. (1997). Oncogene, 15, 1425-1435.
31. Nishizaki T, Chew K, Chu L, Isola J, Kallioniemi A, Weidner N and Waldman FM. (1997). Int. J. Cancer., 74, 513-517.
32. O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM and Allred DC. (1998). J. Natl. Cancer Inst., 90, 697-703.
33. Ossina NK, Cunnas A, Powers VC, Fitzpatrick PA, Knight JD, Gilbert JR, Shekhtman FM, Tomes LD, Umaasky SR and Kiefer MC. (1997). J. Biol. Chem., 272, 16351-16357.
34. Paulson TG, Galipeau PC and Reid BJ. (1999). Genome Res., 9, 482-491.
35. Reed JC. (1999). J. Clin. Oncol., 17, 2941-2953.
36. Sanceau J, Hiscott J, Delattre O and Wietzerbin J. (2000). Oncogene, 19, 3372-3383.
37. Sangfelt Strander H. (2001). Med. Oncol., 18, 3-14.
38. Skaar TC, Prasad SC, Sharareh S, Lippman ME, Brunner N and Clarke R. (1998). J. Steroid Biochem. Mol. Biol., 67, 391-402.
39. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR and Martin SJ. (1999). J. Cell. Biol., 144, 281-292.
40. Spink J and Evans T. (1997). J. Biol. Chem., 272, 24417-24425.
41. Takahashi Y, Geller DA, Gambotto A, Watkins SC, Fung JJ and Murase N. (2000). Surgery, 128, 345-352.
42. Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, Matsuyama T, Mak TW, Taki S and Taniguchi T. (1995). Nature, 376, 596-599.
43. Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, Lamphier MS, Aizawa S, Mak TW and Taniguchi T. (1994a). Cell, 77, 829-839.
44. Tanaka N, Ishihara M and Taniguchi T. (1994b). Cancer Lett., 83, 191-196.
45. Tanaka N and Taniguchi T. (2000). Semin. Cancer Biol., 10, 73-81.
46. Taniguchi T, Ogasawara K, Takaoka A and Tanaka N. (2001). Annu. Rev. Immunol., 19, 623-655.
47. Thornberry NA and Lazebnik Y. (1998). Science, 281, 1312-1316.
48. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J and Kallioniemi OP. (1998). Cancer, 21, 177-184.
49. Tomita Y, Bilim V, Hara N, Kasahara T and Takahashi K. (2003). Int. J. Cancer, 104, 400-408.
50. Ulrich E, Kauffmann-Zeh A, Hueber AO, Williamson J, Chittenden T, Ma A and Evan G. (1997). Genomics, 44, 195-200.
51. Wolf B and Green DR. (1999). J Biol. Chem., 274, 20049-20052.
52. Yim JH, Wu SJ, Casey MJ, Norton JA and Doherty GM. (1997). J. Immunol., 158, 1284-1292.
53. Yim JH, Wu SJ, Lowney JK, Vander Velde TL and Doherty GM. (1999). J. Interferon Cytokine Res., 19, 723-729.